165 related articles for article (PubMed ID: 15222892)
1. Rizatriptan versus rizatriptan plus rofecoxib versus rizatriptan plus tolfenamic acid in the acute treatment of migraine.
Krymchantowski AV; Bigal ME
BMC Neurol; 2004 Jun; 4():10. PubMed ID: 15222892
[TBL] [Abstract][Full Text] [Related]
2. Rizatriptan combined with rofecoxib vs. rizatriptan for the acute treatment of migraine: an open label pilot study.
Krymchantowski AV; Barbosa JS
Cephalalgia; 2002 May; 22(4):309-12. PubMed ID: 12100094
[TBL] [Abstract][Full Text] [Related]
3. Dexamethasone decreases migraine recurrence observed after treatment with a triptan combined with a nonsteroidal anti-inflammatory drug.
Krymchantowski AV; Barbosa JS
Arq Neuropsiquiatr; 2001 Sep; 59(3-B):708-11. PubMed ID: 11593269
[TBL] [Abstract][Full Text] [Related]
4. Rizatriptan vs. rizatriptan plus trimebutine for the acute treatment of migraine: a double-blind, randomized, cross-over, placebo-controlled study.
Krymchantowski AV; Filho PF; Bigal ME
Cephalalgia; 2006 Jul; 26(7):871-4. PubMed ID: 16776704
[TBL] [Abstract][Full Text] [Related]
5. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies.
Visser WH; Winner P; Strohmaier K; Klipfel M; Peng Y; McCarroll K; Cady R; Lewis D; Nett R;
Headache; 2004 Oct; 44(9):891-9. PubMed ID: 15447698
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of coadministration of rizatriptan and acetaminophen vs rizatriptan or acetaminophen alone for acute migraine treatment.
Freitag F; Diamond M; Diamond S; Janssen I; Rodgers A; Skobieranda F
Headache; 2008 Jun; 48(6):921-30. PubMed ID: 18572432
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and pharmacokinetic activity of frovatriptan compared to rizatriptan in patients with moderate-to-severe migraine.
Savi L; Mogavero S; Egan CG
Drug Des Devel Ther; 2014; 8():983-92. PubMed ID: 25092964
[TBL] [Abstract][Full Text] [Related]
8. Rizatriptan vs. ibuprofen in migraine: a randomised placebo-controlled trial.
Misra UK; Kalita J; Yadav RK
J Headache Pain; 2007 Jun; 8(3):175-9. PubMed ID: 17563841
[TBL] [Abstract][Full Text] [Related]
9. A placebo-controlled crossover study of rizatriptan in the treatment of multiple migraine attacks. Rizatriptan Multiple Attack Study Group.
Kramer MS; Matzura-Wolfe D; Polis A; Getson A; Amaraneni PG; Solbach MP; McHugh W; Feighner J; Silberstein S; Reines SA
Neurology; 1998 Sep; 51(3):773-81. PubMed ID: 9748025
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study versus rizatriptan.
Savi L; Omboni S; Lisotto C; Zanchin G; Ferrari MD; Zava D; Pinessi L
J Headache Pain; 2011 Dec; 12(6):609-15. PubMed ID: 21842274
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of rizatriptan for the treatment of acute migraine in sumatriptan non-responders.
Seeburger JL; Taylor FR; Friedman D; Newman L; Ge Y; Zhang Y; Hustad CM; Lasorda J; Fan X; Hewitt D; Ho T; Connor KM
Cephalalgia; 2011 May; 31(7):786-96. PubMed ID: 21078681
[TBL] [Abstract][Full Text] [Related]
12. Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis.
Seeburger JL; Cady RK; Winner P; MacGregor A; Valade D; Ge Y; Zhang Y; Hustad CM; Strickler N; Schaefer E; Connor KM; Ho TW
Headache; 2012 Jan; 52(1):57-67. PubMed ID: 22078129
[TBL] [Abstract][Full Text] [Related]
13. Crossover comparison of efficacy and preference for rizatriptan 10 mg versus ergotamine/caffeine in migraine.
Christie S; Göbel H; Mateos V; Allen C; Vrijens F; Shivaprakash M;
Eur Neurol; 2003; 49(1):20-9. PubMed ID: 12464714
[TBL] [Abstract][Full Text] [Related]
14. Further evaluation of rizatriptan in menstrual migraine: retrospective analysis of long-term data.
Silberstein SD; Massiou H; McCarroll KA; Lines CR
Headache; 2002 Oct; 42(9):917-23. PubMed ID: 12390621
[TBL] [Abstract][Full Text] [Related]
15. Long-term efficacy and tolerability of rizatriptan wafers in migraine.
Cady R; Crawford G; Ahrens S; Hairwassers D; Getson A; Visser WH; Lines C;
MedGenMed; 2001 Jun; 3(3):1. PubMed ID: 11549974
[TBL] [Abstract][Full Text] [Related]
16. Patient preference in migraine therapy. A randomized, open-label, crossover clinical trial of acute treatment of migraine with oral almotriptan and rizatriptan.
Díez FI; Straube A; Zanchin G
J Neurol; 2007 Feb; 254(2):242-9. PubMed ID: 17334957
[TBL] [Abstract][Full Text] [Related]
17. Early treatment of migraine with rizatriptan: a placebo-controlled study.
Mathew NT; Kailasam J; Meadors L
Headache; 2004; 44(7):669-73. PubMed ID: 15209688
[TBL] [Abstract][Full Text] [Related]
18. Almotriptan versus rizatriptan in patients with migraine in Spain.
Leira R; Dualde E; del Barrio H; Machuca M; López-Gil A;
Headache; 2003; 43(7):734-41. PubMed ID: 12890128
[TBL] [Abstract][Full Text] [Related]
19. A double-blind, randomized, multicenter, Italian study of frovatriptan versus rizatriptan for the acute treatment of migraine.
Savi L; Omboni S; Lisotto C; Zanchin G; Ferrari MD; Zava D; Pinessi L
J Headache Pain; 2011 Apr; 12(2):219-26. PubMed ID: 20686810
[TBL] [Abstract][Full Text] [Related]
20. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: a randomized, double-blind, placebo-controlled study.
Winner P; Lewis D; Visser WH; Jiang K; Ahrens S; Evans JK;
Headache; 2002 Jan; 42(1):49-55. PubMed ID: 12005275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
